Filing Details
- Accession Number:
- 0001317757-11-000024
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-08-08 13:00:00
- Reporting Period:
- 2011-08-05
- Filing Date:
- 2011-08-08
- Accepted Time:
- 2011-08-08 16:00:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
792977 | Amag Pharmaceuticals Inc. | AMAG | Pharmaceutical Preparations (2834) | 042742593 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1317757 | L Joseph Farmer | C/O Amag Pharmaceuticals, Inc. 100 Hayden Avenue Lexington MA 02421 | Svp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-08-05 | 2,500 | $0.00 | 2,500 | No | 4 | C | Direct | |
Common Stock | Disposition | 2011-08-05 | 2,500 | $15.71 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Unit | Acquisiton | 2011-08-05 | 2,500 | $0.00 | 2,500 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,500 | No | 4 | C | Direct |
Footnotes
- The shares were acquired by the reporting person as a result of the partial vesting of a restricted stock unit grant described below.
- Not applicable.
- The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
- Each restricted stock unit represents a contingent right to receive one share of common stock.
- Grant of restricted stock unit pursuant to the AMAG Pharmaceuticals, Inc. Second Amended and Restated 2007 Equity Incentive Plan. This grant vests as follows: 50% on August 5, 2010, 25% on August 5, 2011 and the remaining 25% on August 5, 2012.